Found 4 articles for: "Methotrexate"
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis
August 2026 | Volume 25 | Issue 8 | Original Article | 695 | Copyright © August 2026
Background: People with psoriasis are at increased risk for nonmelanoma skin cancers (NMSC) and melanoma. Conventional immunosuppressants and TNF-α inhibitors may further i...
Read MoreMethotrexate Test Dose Use and Frequency of Laboratory Abnormalities in Patients Initiating Treatment
November 2025 | Volume 24 | Issue 11 | Original Article | 1132 | Copyright © November 2025
Background: Recent guidelines within the dermatology literature have indicated that a methotrexate test dose may not be needed for patients at lower risk of toxicity. However, fe...
Read MoreOpt for Methotrexate Before Biologics in the Treatment of Recalcitrant Delayed-Onset Reactions to Dermal Fillers
October 2024 | Volume 23 | Issue 10 | Editorials | 907 | Copyright © October 2024
Methotrexate Monitoring in Dermatology— A Retrospective Cohort Study
March 2021 | Volume 20 | Issue 3 | Original Article | 320 | Copyright © March 2021
Background and Objectives: There are currently no evidence-based recommendations to guide lab monitoring in the first 90 days of methotrexate treatment. The purpose of this study was ...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.